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Cyclic nucleotide signalling plays a key role in regulating
neurite outgrowth in developmental and injury settings.
The functional consequences of enhanced cyclic nucle-
otide signalling on processes that contribute to neurite
outgrowth varies across neuronal cell type, age, cellular
environment, and endpoints evaluated. We have evalu-
ated the potential for neurite outgrowth in cultured
embryonic cortical neurons in the presence and absence
of selective inhibitors of many different phosphodieste-
rases. We observe differential enhanced outgrowth of sev-
eral parameters of neurite outgrowth measured using the
Array Scan automated image analysis platform. DT-2, a
selective inhibitor of PKG, dose dependently inhibited
neurite outgrowth in this culture system and precluded
PDE inhibitor mediated potentiation of neurite out-
growth parameters, including the enhancements pro-
duced by the cAMP PDE4 inhibitor, rolipram. By contrast,
a selective inhibitor of PKA, PKI had no effect on neurite
outgrowth in this culture system. These studies suggest
that embryonic cortical neurons are critically dependent
on PKG activity for neurite outgrowth. The finding that
inhibitors of a cAMP PDE can facilitate neurite outgrowth
in a PKG dependent fashion suggests that cAMP mediated
enhancement of outgrowth still requires a PKG dependent
step to express the potentiating effects on neurite out-
growth.
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